CA2752247C - Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm - Google Patents
Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm Download PDFInfo
- Publication number
- CA2752247C CA2752247C CA2752247A CA2752247A CA2752247C CA 2752247 C CA2752247 C CA 2752247C CA 2752247 A CA2752247 A CA 2752247A CA 2752247 A CA2752247 A CA 2752247A CA 2752247 C CA2752247 C CA 2752247C
- Authority
- CA
- Canada
- Prior art keywords
- nozzle
- cells
- sperm
- stream
- pulse
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims description 637
- 241001465754 Metazoa Species 0.000 title claims description 43
- 239000002245 particle Substances 0.000 title description 1190
- 210000004027 cell Anatomy 0.000 claims abstract description 1362
- 239000012530 fluid Substances 0.000 claims abstract description 884
- 238000000684 flow cytometry Methods 0.000 claims abstract description 300
- 210000000349 chromosome Anatomy 0.000 claims abstract description 21
- 230000004323 axial length Effects 0.000 claims description 16
- 239000011248 coating agent Substances 0.000 claims description 6
- 238000000576 coating method Methods 0.000 claims description 6
- 239000000523 sample Substances 0.000 description 235
- 238000012384 transportation and delivery Methods 0.000 description 199
- 230000006870 function Effects 0.000 description 174
- 238000010186 staining Methods 0.000 description 127
- 239000000203 mixture Substances 0.000 description 113
- 230000008569 process Effects 0.000 description 100
- 238000005286 illumination Methods 0.000 description 96
- 108020004414 DNA Proteins 0.000 description 95
- 210000000582 semen Anatomy 0.000 description 94
- 238000001816 cooling Methods 0.000 description 87
- 238000012545 processing Methods 0.000 description 72
- 230000005670 electromagnetic radiation Effects 0.000 description 68
- 239000000872 buffer Substances 0.000 description 67
- 230000004899 motility Effects 0.000 description 65
- 239000000725 suspension Substances 0.000 description 64
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 64
- 238000001514 detection method Methods 0.000 description 60
- 239000002577 cryoprotective agent Substances 0.000 description 59
- 108090000623 proteins and genes Proteins 0.000 description 54
- 102000004169 proteins and genes Human genes 0.000 description 53
- 239000000975 dye Substances 0.000 description 50
- 239000010902 straw Substances 0.000 description 50
- 238000001914 filtration Methods 0.000 description 47
- 238000005138 cryopreservation Methods 0.000 description 45
- 238000007600 charging Methods 0.000 description 44
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 42
- 239000002699 waste material Substances 0.000 description 40
- 210000001766 X chromosome Anatomy 0.000 description 38
- 230000007423 decrease Effects 0.000 description 38
- PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 description 37
- 238000010586 diagram Methods 0.000 description 37
- 210000004940 nucleus Anatomy 0.000 description 37
- 238000005070 sampling Methods 0.000 description 36
- 238000012360 testing method Methods 0.000 description 36
- 230000008832 photodamage Effects 0.000 description 35
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 34
- 241000283690 Bos taurus Species 0.000 description 34
- 238000005119 centrifugation Methods 0.000 description 34
- 238000011084 recovery Methods 0.000 description 34
- 238000011144 upstream manufacturing Methods 0.000 description 34
- 238000011217 control strategy Methods 0.000 description 33
- 108010000912 Egg Proteins Proteins 0.000 description 32
- 102000002322 Egg Proteins Human genes 0.000 description 32
- 238000004163 cytometry Methods 0.000 description 32
- 210000002969 egg yolk Anatomy 0.000 description 32
- 235000013345 egg yolk Nutrition 0.000 description 32
- 238000004422 calculation algorithm Methods 0.000 description 31
- 210000002593 Y chromosome Anatomy 0.000 description 30
- 239000000654 additive Substances 0.000 description 29
- 230000003287 optical effect Effects 0.000 description 29
- 230000003247 decreasing effect Effects 0.000 description 28
- 238000009826 distribution Methods 0.000 description 28
- 239000000243 solution Substances 0.000 description 28
- 239000008366 buffered solution Substances 0.000 description 27
- 238000004458 analytical method Methods 0.000 description 26
- 230000015572 biosynthetic process Effects 0.000 description 26
- 239000000463 material Substances 0.000 description 26
- 230000008901 benefit Effects 0.000 description 25
- 239000008188 pellet Substances 0.000 description 25
- 239000006228 supernatant Substances 0.000 description 25
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 24
- 238000000605 extraction Methods 0.000 description 24
- 230000008859 change Effects 0.000 description 23
- 239000007789 gas Substances 0.000 description 23
- 230000009027 insemination Effects 0.000 description 23
- 244000309464 bull Species 0.000 description 22
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 20
- 229940098773 bovine serum albumin Drugs 0.000 description 20
- 238000002474 experimental method Methods 0.000 description 19
- 239000007788 liquid Substances 0.000 description 19
- 239000002953 phosphate buffered saline Substances 0.000 description 19
- 238000013459 approach Methods 0.000 description 18
- 230000009021 linear effect Effects 0.000 description 18
- 239000000284 extract Substances 0.000 description 17
- 229910052757 nitrogen Inorganic materials 0.000 description 17
- 239000007853 buffer solution Substances 0.000 description 16
- 230000006378 damage Effects 0.000 description 16
- 230000006872 improvement Effects 0.000 description 16
- 235000013336 milk Nutrition 0.000 description 16
- 239000008267 milk Substances 0.000 description 16
- 210000004080 milk Anatomy 0.000 description 16
- 238000000926 separation method Methods 0.000 description 16
- 230000035899 viability Effects 0.000 description 16
- 239000003242 anti bacterial agent Substances 0.000 description 15
- 239000013611 chromosomal DNA Substances 0.000 description 15
- 238000010790 dilution Methods 0.000 description 15
- 239000012895 dilution Substances 0.000 description 15
- 238000005516 engineering process Methods 0.000 description 15
- 230000000750 progressive effect Effects 0.000 description 15
- 238000011109 contamination Methods 0.000 description 14
- 230000000694 effects Effects 0.000 description 14
- 230000033001 locomotion Effects 0.000 description 14
- 230000007246 mechanism Effects 0.000 description 14
- 230000019100 sperm motility Effects 0.000 description 14
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 14
- 239000004606 Fillers/Extenders Substances 0.000 description 13
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 13
- 238000005520 cutting process Methods 0.000 description 13
- 238000005259 measurement Methods 0.000 description 13
- 229940076788 pyruvate Drugs 0.000 description 13
- 238000003908 quality control method Methods 0.000 description 13
- 238000004781 supercooling Methods 0.000 description 13
- 239000013598 vector Substances 0.000 description 13
- 230000002759 chromosomal effect Effects 0.000 description 12
- 238000004891 communication Methods 0.000 description 12
- 230000036541 health Effects 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 12
- 230000003647 oxidation Effects 0.000 description 12
- 238000007254 oxidation reaction Methods 0.000 description 12
- 238000006722 reduction reaction Methods 0.000 description 12
- 230000035939 shock Effects 0.000 description 12
- 235000017557 sodium bicarbonate Nutrition 0.000 description 12
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 12
- 238000011156 evaluation Methods 0.000 description 11
- 230000010287 polarization Effects 0.000 description 11
- 239000000835 fiber Substances 0.000 description 10
- 239000003112 inhibitor Substances 0.000 description 10
- 239000011736 potassium bicarbonate Substances 0.000 description 10
- 235000015497 potassium bicarbonate Nutrition 0.000 description 10
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 10
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 10
- 241000124008 Mammalia Species 0.000 description 9
- 230000003115 biocidal effect Effects 0.000 description 9
- 238000004140 cleaning Methods 0.000 description 9
- 230000005284 excitation Effects 0.000 description 9
- 239000002609 medium Substances 0.000 description 9
- 239000012528 membrane Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- -1 2-hydroxy-1,1-bis[hydroxymethyl] ethyl Chemical group 0.000 description 8
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 8
- 108010073771 Soybean Proteins Proteins 0.000 description 8
- 238000012937 correction Methods 0.000 description 8
- 238000002347 injection Methods 0.000 description 8
- 239000007924 injection Substances 0.000 description 8
- 239000011734 sodium Substances 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 229940001941 soy protein Drugs 0.000 description 8
- 238000003860 storage Methods 0.000 description 8
- 108010077544 Chromatin Proteins 0.000 description 7
- 229930091371 Fructose Natural products 0.000 description 7
- 239000005715 Fructose Substances 0.000 description 7
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 7
- 230000005540 biological transmission Effects 0.000 description 7
- 210000003483 chromatin Anatomy 0.000 description 7
- 239000007850 fluorescent dye Substances 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- 238000011068 loading method Methods 0.000 description 7
- 230000007935 neutral effect Effects 0.000 description 7
- 238000002203 pretreatment Methods 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- 230000004044 response Effects 0.000 description 7
- 238000013519 translation Methods 0.000 description 7
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 6
- 229940088710 antibiotic agent Drugs 0.000 description 6
- 230000009286 beneficial effect Effects 0.000 description 6
- 229920002301 cellulose acetate Polymers 0.000 description 6
- 239000012141 concentrate Substances 0.000 description 6
- 238000007796 conventional method Methods 0.000 description 6
- 230000005684 electric field Effects 0.000 description 6
- 238000011067 equilibration Methods 0.000 description 6
- 239000012595 freezing medium Substances 0.000 description 6
- 230000005484 gravity Effects 0.000 description 6
- 230000003993 interaction Effects 0.000 description 6
- 238000012544 monitoring process Methods 0.000 description 6
- 239000011148 porous material Substances 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 229930003448 Vitamin K Natural products 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 238000009395 breeding Methods 0.000 description 5
- 230000001488 breeding effect Effects 0.000 description 5
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 230000001627 detrimental effect Effects 0.000 description 5
- 230000004720 fertilization Effects 0.000 description 5
- 239000000834 fixative Substances 0.000 description 5
- 230000010354 integration Effects 0.000 description 5
- 230000002503 metabolic effect Effects 0.000 description 5
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 230000001360 synchronised effect Effects 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 210000001215 vagina Anatomy 0.000 description 5
- 235000019168 vitamin K Nutrition 0.000 description 5
- 239000011712 vitamin K Substances 0.000 description 5
- 150000003721 vitamin K derivatives Chemical class 0.000 description 5
- 229940046010 vitamin k Drugs 0.000 description 5
- 101100096719 Arabidopsis thaliana SSL2 gene Proteins 0.000 description 4
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- 101100366560 Panax ginseng SS10 gene Proteins 0.000 description 4
- 239000004743 Polypropylene Substances 0.000 description 4
- 239000007983 Tris buffer Substances 0.000 description 4
- 229960002303 citric acid monohydrate Drugs 0.000 description 4
- 230000006835 compression Effects 0.000 description 4
- 238000007906 compression Methods 0.000 description 4
- 238000005094 computer simulation Methods 0.000 description 4
- 230000003750 conditioning effect Effects 0.000 description 4
- 235000013365 dairy product Nutrition 0.000 description 4
- 238000013523 data management Methods 0.000 description 4
- 230000035558 fertility Effects 0.000 description 4
- 238000007710 freezing Methods 0.000 description 4
- 230000008014 freezing Effects 0.000 description 4
- 230000009477 glass transition Effects 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 4
- 235000019136 lipoic acid Nutrition 0.000 description 4
- 230000004807 localization Effects 0.000 description 4
- 230000003204 osmotic effect Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 229940107700 pyruvic acid Drugs 0.000 description 4
- 239000002002 slurry Substances 0.000 description 4
- 238000002791 soaking Methods 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 230000008010 sperm capacitation Effects 0.000 description 4
- 229960002663 thioctic acid Drugs 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- 101001130128 Arabidopsis thaliana Leucoanthocyanidin dioxygenase Proteins 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 102000019197 Superoxide Dismutase Human genes 0.000 description 3
- 108010012715 Superoxide dismutase Proteins 0.000 description 3
- 230000001133 acceleration Effects 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 230000003139 buffering effect Effects 0.000 description 3
- 230000009087 cell motility Effects 0.000 description 3
- 229960004106 citric acid Drugs 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 210000003765 sex chromosome Anatomy 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 230000003595 spectral effect Effects 0.000 description 3
- 230000002459 sustained effect Effects 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 101100366707 Arabidopsis thaliana SSL11 gene Proteins 0.000 description 2
- 101150108928 CCC1 gene Proteins 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 2
- 241000283073 Equus caballus Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- 238000002679 ablation Methods 0.000 description 2
- 229940008201 allegra Drugs 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 238000003975 animal breeding Methods 0.000 description 2
- 230000002547 anomalous effect Effects 0.000 description 2
- 230000003667 anti-reflective effect Effects 0.000 description 2
- 238000000429 assembly Methods 0.000 description 2
- 230000000712 assembly Effects 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 208000036552 dowling-degos disease 3 Diseases 0.000 description 2
- 201000010063 epididymitis Diseases 0.000 description 2
- 208000005244 familial abdominal 2 aortic aneurysm Diseases 0.000 description 2
- 208000002153 familial abdominal 3 aortic aneurysm Diseases 0.000 description 2
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical compound C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 239000005350 fused silica glass Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 238000003064 k means clustering Methods 0.000 description 2
- 238000003475 lamination Methods 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000000520 microinjection Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000003973 paint Substances 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 229960000268 spectinomycin Drugs 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 238000013024 troubleshooting Methods 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- LRZSAGKIMYFLHY-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;dihydrate Chemical compound O.O.OC(=O)CC(O)(C(O)=O)CC(O)=O LRZSAGKIMYFLHY-UHFFFAOYSA-N 0.000 description 1
- 229920002972 Acrylic fiber Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 101100116283 Arabidopsis thaliana DD11 gene Proteins 0.000 description 1
- 101100064317 Arabidopsis thaliana DTX41 gene Proteins 0.000 description 1
- 101100366711 Arabidopsis thaliana SSL13 gene Proteins 0.000 description 1
- 101100398584 Arabidopsis thaliana TT10 gene Proteins 0.000 description 1
- 101100047785 Arabidopsis thaliana TT16 gene Proteins 0.000 description 1
- 241001417094 Bregmacerotidae Species 0.000 description 1
- 101150050425 CCC2 gene Proteins 0.000 description 1
- 241000272194 Ciconiiformes Species 0.000 description 1
- 241000234600 Costus Species 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 101000642815 Homo sapiens Protein SSXT Proteins 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000471154 Lithodesmium variabile Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 101100366561 Panax ginseng SS11 gene Proteins 0.000 description 1
- 101100366562 Panax ginseng SS12 gene Proteins 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 102100035586 Protein SSXT Human genes 0.000 description 1
- 235000006784 Saussurea lappa Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 229930194936 Tylosin Natural products 0.000 description 1
- 239000004182 Tylosin Substances 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- ONXOKWFYBIQOFQ-VSXSCALHSA-N ac1l4s0d Chemical compound OS(O)(=O)=O.O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O.O[C@@H]1[C@H](O)[C@@H](O)[C@@H](SC)O[C@@H]1[C@@H]([C@@H](C)O)NC(=O)[C@H]1N(C)C[C@H](C(C)C)C1 ONXOKWFYBIQOFQ-VSXSCALHSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 238000001152 differential interference contrast microscopy Methods 0.000 description 1
- 238000010252 digital analysis Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical class [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 1
- 238000005315 distribution function Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000007786 electrostatic charging Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 210000000918 epididymis Anatomy 0.000 description 1
- 208000034199 familial abdominal 4 aortic aneurysm Diseases 0.000 description 1
- 210000005002 female reproductive tract Anatomy 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 150000002211 flavins Chemical class 0.000 description 1
- 239000005308 flint glass Substances 0.000 description 1
- 238000005188 flotation Methods 0.000 description 1
- 238000002421 fluorescence-activated droplet sorting Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000009652 hydrodynamic focusing Methods 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000010365 information processing Effects 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000003893 lactate salts Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000000608 laser ablation Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- MJFJKKXQDNNUJF-UHFFFAOYSA-N metixene Chemical compound C1N(C)CCCC1CC1C2=CC=CC=C2SC2=CC=CC=C21 MJFJKKXQDNNUJF-UHFFFAOYSA-N 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 239000002991 molded plastic Substances 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000009022 nonlinear effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 238000012950 reanalysis Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 229910052594 sapphire Inorganic materials 0.000 description 1
- 239000010980 sapphire Substances 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 238000010583 slow cooling Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 1
- 231100000469 sperm hypomotility Toxicity 0.000 description 1
- 238000003879 sperm preservation Methods 0.000 description 1
- 230000009303 sperm storage Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000007447 staining method Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- OHKOGUYZJXTSFX-KZFFXBSXSA-N ticarcillin Chemical compound C=1([C@@H](C(O)=O)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)C=CSC=1 OHKOGUYZJXTSFX-KZFFXBSXSA-N 0.000 description 1
- 229960004659 ticarcillin Drugs 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 238000007514 turning Methods 0.000 description 1
- 229960004059 tylosin Drugs 0.000 description 1
- WBPYTXDJUQJLPQ-VMXQISHHSA-N tylosin Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 WBPYTXDJUQJLPQ-VMXQISHHSA-N 0.000 description 1
- 235000019375 tylosin Nutrition 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
- 238000001429 visible spectrum Methods 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45860703P | 2003-03-28 | 2003-03-28 | |
| US45873103P | 2003-03-28 | 2003-03-28 | |
| US60/458,607 | 2003-03-28 | ||
| US60/458,731 | 2003-03-28 | ||
| CA2518882A CA2518882C (en) | 2003-03-28 | 2004-03-29 | Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2518882A Division CA2518882C (en) | 2003-03-28 | 2004-03-29 | Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2752247A1 CA2752247A1 (en) | 2004-10-14 |
| CA2752247C true CA2752247C (en) | 2014-06-17 |
Family
ID=41494485
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2752244A Expired - Lifetime CA2752244C (en) | 2003-03-28 | 2004-03-29 | Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm |
| CA2752247A Expired - Lifetime CA2752247C (en) | 2003-03-28 | 2004-03-29 | Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm |
| CA2752312A Expired - Lifetime CA2752312C (en) | 2003-03-28 | 2004-03-29 | Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm |
| CA3002927A Expired - Lifetime CA3002927C (en) | 2003-03-28 | 2004-03-29 | Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm |
| CA2752218A Expired - Lifetime CA2752218C (en) | 2003-03-28 | 2004-03-29 | Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2752244A Expired - Lifetime CA2752244C (en) | 2003-03-28 | 2004-03-29 | Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2752312A Expired - Lifetime CA2752312C (en) | 2003-03-28 | 2004-03-29 | Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm |
| CA3002927A Expired - Lifetime CA3002927C (en) | 2003-03-28 | 2004-03-29 | Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm |
| CA2752218A Expired - Lifetime CA2752218C (en) | 2003-03-28 | 2004-03-29 | Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN101614731A (zh) |
| CA (5) | CA2752244C (zh) |
| ZA (1) | ZA200507151B (zh) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2305832B1 (en) | 2003-03-28 | 2022-03-09 | Inguran, LLC | Method for providing sex-sorted animal sperm |
| CN103013811A (zh) * | 2011-09-20 | 2013-04-03 | 北京富通华投资有限公司 | 精子分选仪 |
| CN103540520B (zh) * | 2013-09-29 | 2015-03-04 | 大连金弘基种畜有限公司 | 椭锥螺纹喷嘴 |
| CN103529036A (zh) * | 2013-10-08 | 2014-01-22 | 南京师范大学 | 一种鉴别杂交黄颡鱼幼鱼性别的方法 |
| HUE038401T2 (hu) * | 2014-09-19 | 2018-10-29 | Instr Utils De Laboratori Geniul Sl | Eljárás sperma minõségének fokozására emlõsökben |
| NL2015796A (en) * | 2014-11-17 | 2016-09-06 | Asml Netherlands Bv | Apparatus. |
| US20180071981A1 (en) | 2015-03-31 | 2018-03-15 | The Regents Of The University Of California | System and method for tunable patterning and assembly of particles via acoustophoresis |
| CN106342789B (zh) * | 2016-10-13 | 2022-07-15 | 深圳韦拓生物科技有限公司 | 一种细胞玻璃化冷冻处理设备及其处理方法 |
| CA3089148A1 (en) | 2017-01-31 | 2018-08-09 | Genea Ip Holdings Pty Limited | Method and system for processing a biological sample |
| EP3579975A4 (en) * | 2017-02-13 | 2021-03-24 | Bio-rad Laboratories, Inc. | SYSTEM, METHOD AND DEVICE FOR FORMING A SERIES OF EMULSIONS |
| CN107126215A (zh) * | 2017-06-15 | 2017-09-05 | 内蒙古智牧溯源技术开发有限公司 | 一种激光牲畜体尺测量装置 |
| CN108041588A (zh) * | 2017-12-08 | 2018-05-18 | 冯纪敏 | 一种含有海藻糖的组合物及其应用 |
| JP7338336B2 (ja) * | 2018-09-10 | 2023-09-05 | ソニーグループ株式会社 | 微小粒子分取装置、細胞治療薬製造装置、微小粒子分取方法、及びプログラム |
| CN110339876B (zh) * | 2019-06-27 | 2021-04-30 | 昆明理工大学 | 一种基于液滴寄存的肿瘤细胞筛查微流控装置及筛查方法 |
| CN110456831B (zh) * | 2019-08-16 | 2022-06-14 | 南开大学 | 一种基于主动视觉的小鼠接触行为追踪平台 |
| CN110923139B (zh) * | 2019-11-29 | 2023-03-10 | 济宁医学院附属医院 | 一种人工辅助生殖精液自动核对及处理系统 |
| CN111474293B (zh) * | 2020-04-27 | 2023-05-05 | 广东博创佳禾科技有限公司 | 一种青枯病菌溶液测定方法及测定系统 |
| CN111895905B (zh) * | 2020-05-27 | 2022-04-19 | 中国计量大学 | 一种用于六方轴直线度检测系统的误差补偿方法 |
| CN111624320B (zh) * | 2020-06-08 | 2022-11-25 | 深圳延浩科技有限公司 | 水质检测装置 |
| CN112763462B (zh) * | 2020-12-31 | 2022-10-14 | 茶陵晶辉电子实业有限公司 | 一种基板玻璃透光率检测设备及基板玻璃制备工艺 |
| CN112795476B (zh) * | 2021-04-15 | 2021-07-02 | 成都齐碳科技有限公司 | 纳米孔测序电路、测序方法及装置 |
| CN114100706B (zh) * | 2021-10-18 | 2022-08-19 | 吉林大学 | 一种基于粒子漂移的粒子分选方法及系统 |
| CN114632726B (zh) * | 2022-03-10 | 2024-05-07 | 九州天禾(山东)智能科技有限公司 | 一种可实时监测防护的喷吹防堵结构 |
| CN115245402B (zh) * | 2022-09-21 | 2022-12-09 | 山东四方新域农牧科技股份有限公司 | 一种家兔集约化养殖用自动受精设备 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2217342A (en) * | 1938-05-19 | 1940-10-08 | Aaron G Ladrach | Time or speed controlled delayed action relay for strip material classifiers |
| US4325483A (en) * | 1979-08-20 | 1982-04-20 | Ortho Diagnostics, Inc. | Method for detecting and controlling flow rates of the droplet forming stream of an electrostatic particle sorting apparatus |
| US5199576A (en) * | 1991-04-05 | 1993-04-06 | University Of Rochester | System for flexibly sorting particles |
| JP3079932B2 (ja) * | 1994-12-28 | 2000-08-21 | 株式会社佐竹製作所 | 穀粒色彩選別装置 |
| US6149867A (en) * | 1997-12-31 | 2000-11-21 | Xy, Inc. | Sheath fluids and collection systems for sex-specific cytometer sorting of sperm |
| WO1999042810A1 (en) * | 1998-02-20 | 1999-08-26 | Xy, Inc. | A vibratory system for a sorting flow cytometer |
| AU2003265471B2 (en) * | 2002-08-15 | 2009-08-06 | Xy, Llc. | High resolution flow cytometer |
-
2004
- 2004-03-29 CA CA2752244A patent/CA2752244C/en not_active Expired - Lifetime
- 2004-03-29 CA CA2752247A patent/CA2752247C/en not_active Expired - Lifetime
- 2004-03-29 CA CA2752312A patent/CA2752312C/en not_active Expired - Lifetime
- 2004-03-29 CA CA3002927A patent/CA3002927C/en not_active Expired - Lifetime
- 2004-03-29 CN CN200910146867A patent/CN101614731A/zh active Pending
- 2004-03-29 CA CA2752218A patent/CA2752218C/en not_active Expired - Lifetime
-
2005
- 2005-09-06 ZA ZA200507151A patent/ZA200507151B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2752244A1 (en) | 2004-10-14 |
| CA2752312A1 (en) | 2004-10-14 |
| CN101614731A (zh) | 2009-12-30 |
| ZA200507151B (en) | 2009-11-25 |
| CA2752218C (en) | 2015-12-08 |
| CA2752244C (en) | 2014-12-16 |
| CA3002927C (en) | 2021-05-04 |
| CA2752312C (en) | 2018-06-19 |
| CA3002927A1 (en) | 2004-10-14 |
| CA2752247A1 (en) | 2004-10-14 |
| CA2752218A1 (en) | 2004-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9377390B2 (en) | Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm | |
| CA2752247C (en) | Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm | |
| AU2012200712B2 (en) | "A process for evaluating staining conditions of cells for sorting" | |
| AU2012200709B2 (en) | "Epi-illumination apparatus and methods for sorting particles" |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |